Liste der für eine Zulassung in Frage kommenden besonders besorgniserregenden Stoffe
Liste der für eine Zulassung in Frage kommenden besonders besorgniserregenden Stoffe
(veröffentlicht gemäß Artikel 59 Absatz 10 der REACH-Verordnung)
Liste der für eine Zulassung in Frage kommenden besonders besorgniserregenden Stoffe
Anmerkungen:
- Verbindliche Fassung: Nur die auf dieser Website veröffentlichte Kandidatenliste ist verbindlich. Unternehmen haben möglicherweise unmittelbare rechtliche Verpflichtungen, die sich aus der Aufnahme eines Stoffes in die Kandidatenliste auf dieser Website ergeben, insbesondere aufgrund von Artikel 7, 31 und 33 der REACH-Verordnung.
- Numerische Identifikatoren: Jeder Eintrag in der Kandidatenliste deckt sowohl die wasserfreie als auch die hydratisierte Form eines Stoffes ab. Die CAS-Nummer eines Eintrags bezieht sich typischerweise auf die wasserfreie Form. Mit anderen CAS-Nummern gekennzeichnete hydratisierte Formen des Stoffes werden ebenfalls von dem Eintrag erfasst.
- Andere numerische Identifikatoren: Bei den Einträgen mit Anführungszeichen in den Spalten der EG-Nummern und CAS-Nummern kann ggf. auf eine nicht erschöpfende Liste von EG- und/oder CAS-Registriernummern zugegriffen werden, in der Stoffe oder Stoffgruppen beschrieben werden, die unter die Kandidatenliste fallen. Diese Informationen können im ausgewählten Eintrag über die Schaltfläche „Details“ angezeigt werden.
Filter the list
The List does not contain any Substances.
Entscheidung | IUCLID-Datensatz | ||||||
---|---|---|---|---|---|---|---|
show/hide
(±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one
EG-Nr. :
253-242-6
| CAS-Nr. :
36861-47-9
(3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EG-Nr. :
-
| CAS-Nr. :
1782069-81-1
(1R,3E,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EG-Nr. :
-
| CAS-Nr. :
95342-41-9
(1S,3E,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EG-Nr. :
-
| CAS-Nr. :
852541-30-1
(1R,3Z,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EG-Nr. :
-
| CAS-Nr. :
852541-21-0
(1R,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EG-Nr. :
-
| CAS-Nr. :
741687-98-9
(1S,3Z,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EG-Nr. :
-
| CAS-Nr. :
852541-25-4
|
-
|
-
|
17-Jan-2022
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5)
show/hide
1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters
EG-Nr. :
272-013-1
| CAS-Nr. :
68648-93-1
|
-
|
-
|
15-Jun-2015
|
Toxic for reproduction (Article 57c) |
Details | ||
covering any of its individual anti- and syn-isomers or any combination thereof
show/hide
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EG-Nr. :
-
| CAS-Nr. :
135821-03-3
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EG-Nr. :
-
| CAS-Nr. :
135821-74-8
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
EG-Nr. :
236-948-9
| CAS-Nr. :
13560-89-9
|
-
|
-
|
15-Jan-2018
|
vPvB (Article 57e) |
Details | ||
show/hide
|
-
|
-
|
08-Jul-2021
|
Carcinogenic (Article 57a) |
Details | ||
covering any of their individual isomers and combinations thereof
show/hide
2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionyl fluoride
EG-Nr. :
218-173-8
| CAS-Nr. :
2062-98-8
potassium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionate
EG-Nr. :
266-578-3
| CAS-Nr. :
67118-55-2
|
-
|
-
|
16-Jul-2019
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
show/hide
|
-
|
-
|
08-Jul-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
show/hide
|
-
|
-
|
19-Dez-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | ||
covering well-defined substances and UVCB substances, polymers and homologues
show/hide
Poly(oxy-1,2-ethanediyl), α-[(1,1,3,3-tetramethylbutyl)phenyl]-ω-hydroxy-
EG-Nr. :
-
| CAS-Nr. :
9036-19-5
20-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-3,6,9,12,15,18-hexaoxaicosan-1-ol
EG-Nr. :
219-682-8
| CAS-Nr. :
2497-59-8
|
-
|
-
|
19-Dez-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
substances with a linear and/or branched alkyl chain with a carbon number of 7 covalently bound predominantly in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
show/hide
|
-
|
-
|
12-Jan-2017
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
show/hide
|
-
|
-
|
19-Dez-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof
show/hide
Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
EG-Nr. :
500-209-1
| CAS-Nr. :
68412-54-4
3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)-, branched
EG-Nr. :
293-926-1
| CAS-Nr. :
91648-64-5
4-Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
EG-Nr. :
500-315-8
| CAS-Nr. :
127087-87-0
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol;
EG-Nr. :
255-695-5
| CAS-Nr. :
42173-90-0
3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(isononylphenoxy)-
EG-Nr. :
-
| CAS-Nr. :
65455-72-3
44-(nonylphenoxy)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontanol
EG-Nr. :
260-678-0
| CAS-Nr. :
57321-10-5
29-(nonylphenoxy)-3,6,9,12,15,18,21,24,27-nonaoxanonacosanol
EG-Nr. :
248-294-1
| CAS-Nr. :
27177-08-8
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol
EG-Nr. :
247-816-5
| CAS-Nr. :
26571-11-9
|
799-990-1
|
-
|
20-Jun-2013
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
covering any of the individual stereoisomers of [1] and [2] or any combination thereof
show/hide
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
EG-Nr. :
-
| CAS-Nr. :
186309-28-4
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
EG-Nr. :
-
| CAS-Nr. :
117933-89-8
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-rel-
EG-Nr. :
-
| CAS-Nr. :
343934-04-3
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EG-Nr. :
-
| CAS-Nr. :
676367-09-2
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-rel-
EG-Nr. :
-
| CAS-Nr. :
343934-05-4
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EG-Nr. :
-
| CAS-Nr. :
676367-04-7
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EG-Nr. :
-
| CAS-Nr. :
676367-08-1
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EG-Nr. :
-
| CAS-Nr. :
676367-03-6
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EG-Nr. :
-
| CAS-Nr. :
676367-07-0
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EG-Nr. :
-
| CAS-Nr. :
676367-02-5
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EG-Nr. :
-
| CAS-Nr. :
676367-06-9
Reaction mass of 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
EG-Nr. :
413-720-9
| CAS-Nr. :
-
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EG-Nr. :
-
| CAS-Nr. :
676367-05-8
|
-
|
-
|
15-Jun-2015
|
vPvB (Article 57e) |
Details | ||
show/hide
|
-
|
-
|
15-Dez-2010
|
Carcinogenic (Article 57a) |
Details | ||
are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium and silicon are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm) c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight
show/hide
|
-
|
-
|
19-Dez-2011
|
Carcinogenic (Article 57a) |
Details | ||
show/hide
|
-
|
-
|
17-Jan-2023
|
vPvB (Article 57e) |
Details | ||
EC No. 233-139-2 and EC No. 234-343-4
show/hide
|
-
|
-
|
18-Jun-2010
|
Toxic for reproduction (Article 57c) |
Details | ||
all possible combinations of the cis- and trans-isomers
show/hide
|
-
|
-
|
19-Dez-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
show/hide
|
-
|
-
|
19-Jan-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
and all major diastereoisomers identified
show/hide
|
-
|
-
|
28-Okt-2008
|
PBT (Article 57d) |
Details | ||
including cis- and trans- stereo isomeric forms and all possible combinations of the isomers
show/hide
|
-
|
-
|
19-Dez-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
UVCB substances consisting of more than or equal to 80% linear chloroalkanes with carbon chain lengths within the range from C14 to C17
show/hide
|
-
|
-
|
08-Jul-2021
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
show/hide
|
-
|
-
|
12-Jan-2017
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | ||
show/hide
|
700-960-7
|
-
|
23-Jan-2024
|
vPvB (Article 57e) |
Details | ||
show/hide
|
-
|
-
|
08-Jul-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
show/hide
1-(4-butoxy-1-naphthalenyl)tetrahydrothiophenium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfonate
EG-Nr. :
468-770-4
| CAS-Nr. :
-
N,N,N-triethylethanaminium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate
EG-Nr. :
-
| CAS-Nr. :
25628-08-4
|
-
|
-
|
16-Jan-2020
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
show/hide
|
-
|
-
|
17-Jan-2023
|
Toxic for reproduction (Article 57c) PBT (Article 57d) vPvB (Article 57e) Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
PFHxS
show/hide
tridecafluorohexanesulphonic acid, compound with 2,2'-iminodiethanol (1:1)
EG-Nr. :
274-462-9
| CAS-Nr. :
70225-16-0
Phosphonium, triphenyl(phenylmethyl)-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
1000597-52-3
Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
1310480-24-0
Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
1310480-27-3
Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(phenylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
1310480-28-4
Beta-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1)
EG-Nr. :
-
| CAS-Nr. :
1329995-45-0
Gamma-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1)
EG-Nr. :
-
| CAS-Nr. :
1329995-69-8
Sulfonium, triphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
144116-10-9
Quinolinium, 1-(carboxymethyl)-4-[2-[4-[4-(2,2-diphenylethenyl)phenyl]-1,2,3,3a,4,8b-hexahydrocyclopent[b]indol-7-yl]ethenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
1462414-59-0
Iodonium, diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
153443-35-7
Methanaminium, N,N,N-trimethyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1)
EG-Nr. :
-
| CAS-Nr. :
189274-31-5
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd.with 2-methyl-2-propanamine (1:1)
EG-Nr. :
-
| CAS-Nr. :
202189-84-2
Iodonium, bis[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
213740-81-9
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, gallium salt (9CI)
EG-Nr. :
-
| CAS-Nr. :
341035-71-0
Sulfonium, bis(4-methylphenyl)phenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
341548-85-4
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, scandium(3+) salt (3:1)
EG-Nr. :
-
| CAS-Nr. :
350836-93-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, neodymium(3+) salt (3:1)
EG-Nr. :
-
| CAS-Nr. :
41184-65-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, yttrium(3+) salt (3:1)
EG-Nr. :
-
| CAS-Nr. :
41242-12-0
Sulfonium, (thiodi-4,1-phenylene)bis[diphenyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:2)
EG-Nr. :
-
| CAS-Nr. :
421555-73-9
Iodonium, bis[4-(1,1-dimethylpropyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic
EG-Nr. :
-
| CAS-Nr. :
421555-74-0
Sulfonium, tris[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
425670-70-8
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, lithium salt (1:1)
EG-Nr. :
-
| CAS-Nr. :
55120-77-9
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, zinc salt
EG-Nr. :
-
| CAS-Nr. :
70136-72-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. with N,N-diethylethanamine (1:1)
EG-Nr. :
-
| CAS-Nr. :
72033-41-1
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, sodium salt
EG-Nr. :
-
| CAS-Nr. :
82382-12-5
Iodonium, bis[(1,1-dimethylethyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1) (9CI)
EG-Nr. :
-
| CAS-Nr. :
866621-50-3
Sulfonium, (4-methylphenyl)diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
910606-39-2
Sulfonium, [4-[(2-methyl-1-oxo-2-propen-1-yl)oxy]phenyl]diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
911027-68-4
Dibenzo[k,n][1,4,7,10,13]tetraoxathiacyclopentadecinium, 19-[4-(1,1-dimethylethyl)phenyl]-6,7,9,10,12,13-hexahydro-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EG-Nr. :
-
| CAS-Nr. :
928049-42-7
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, cesium salt (1:1)
EG-Nr. :
-
| CAS-Nr. :
92011-17-1
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. With pyrrolidine (1:1)
EG-Nr. :
-
| CAS-Nr. :
1187817-57-7
|
-
|
-
|
07-Jul-2017
|
vPvB (Article 57e) |
Details | ||
show/hide
|
-
|
-
|
17-Dez-2015
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | ||
show/hide
|
-
|
-
|
08-Jul-2021
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
473-390-7
|
-
|
17-Jan-2023
|
vPvB (Article 57e) |
Details | |||
-
|
-
|
17-Dez-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
show/hide
Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs.
EG-Nr. :
-
| CAS-Nr. :
1471311-26-8
Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine
EG-Nr. :
300-298-5
| CAS-Nr. :
93925-00-9
|
-
|
-
|
15-Jan-2018
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
show/hide
Borate(2-), tetrahydroxybis[μ-(peroxy-κO1:κO2)]di-, sodium, hydrate (1:2:6)
EG-Nr. :
-
| CAS-Nr. :
125022-34-6
|
-
|
-
|
16-Jun-2014
|
Toxic for reproduction (Article 57c) |
Details | ||
show/hide
|
-
|
-
|
16-Jul-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium, silicon and zirconium are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm). c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight
show/hide
|
-
|
-
|
19-Dez-2011
|
Carcinogenic (Article 57a) |
Details | ||
233-245-9
|
10099-74-8
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
202-918-9
|
101-14-4
|
19-Dez-2011
|
Carcinogenic (Article 57a) |
Details | |||
202-959-2
|
101-61-1
|
18-Jun-2012
|
Carcinogenic (Article 57a) |
Details | |||
202-974-4
|
101-77-9
|
28-Okt-2008
|
Carcinogenic (Article 57a) |
Details | |||
show/hide
|
233-296-7
|
10108-64-2
|
16-Jun-2014
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | ||
show/hide
|
233-331-6
|
10124-36-4, 31119-53-6
|
17-Dez-2014
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | ||
233-334-2
|
10124-43-3
|
15-Dez-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
233-402-1
|
10141-05-6
|
15-Dez-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
233-710-6
|
10325-94-7
|
15-Jan-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
234-190-3
|
10588-01-9, 7789-12-0
|
28-Okt-2008
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
203-445-0
|
106-94-5
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
213-934-0
|
1067-53-4
|
17-Jan-2022
|
Toxic for reproduction (Article 57c) |
Details | |||
203-458-1
|
107-06-2
|
19-Dez-2011
|
Carcinogenic (Article 57a) |
Details | |||
EDA
|
203-468-6
|
107-15-3
|
27-Jun-2018
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
214-012-0
|
1072-63-5
|
25-Jun-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
203-615-4
|
108-78-1
|
17-Jan-2023
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | |||
203-713-7
|
109-86-4
|
15-Dez-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
203-727-3
|
110-00-9
|
19-Dez-2012
|
Carcinogenic (Article 57a) |
Details | |||
203-772-9
|
110-49-6
|
16-Jul-2019
|
Toxic for reproduction (Article 57c) |
Details | |||
203-794-9
|
110-71-4
|
18-Jun-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
203-804-1
|
110-80-5
|
15-Dez-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
203-839-2
|
111-15-9
|
20-Jun-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
203-856-5
|
111-30-8
|
08-Jul-2021
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | |||
203-924-4
|
111-96-6
|
19-Dez-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
234-329-8
|
11103-86-9
|
19-Dez-2011
|
Carcinogenic (Article 57a) |
Details | |||
234-363-3
|
11120-22-2
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
203-977-3
|
112-49-2
|
18-Jun-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
214-317-9
|
1120-71-4
|
17-Dez-2015
|
Carcinogenic (Article 57a) |
Details | |||
204-118-5
|
115-96-8
|
13-Jan-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
214-604-9
|
1163-19-5
|
19-Dez-2012
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
204-211-0
|
117-81-7
|
28-Okt-2008
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
204-212-6
|
117-82-8
|
19-Dez-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
204-327-1
|
119-47-1
|
17-Jan-2022
|
Toxic for reproduction (Article 57c) |
Details | |||
CG 25-369; IRGACURE 369; TK 11-319
|
404-360-3
|
119313-12-1
|
16-Jan-2020
|
Toxic for reproduction (Article 57c) |
Details | ||
438-340-0
|
119344-86-4
|
23-Jan-2024
|
Toxic for reproduction (Article 57c) |
Details | |||
204-371-1
|
120-12-7
|
28-Okt-2008
|
PBT (Article 57d) |
Details | |||
204-419-1
|
120-71-8
|
19-Dez-2012
|
Carcinogenic (Article 57a) |
Details | |||
234-541-0
|
12008-41-2
|
27-Jun-2018
|
Toxic for reproduction (Article 57c) |
Details | |||
234-853-7
|
12036-76-9
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
235-038-9
|
12060-00-3
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
235-067-7
|
12065-90-6
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
204-450-0
|
121-14-2
|
13-Jan-2010
|
Carcinogenic (Article 57a) |
Details | |||
235-252-2
|
12141-20-7
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
215-540-4
|
12179-04-3, 1303-96-4, 1330-43-4
|
18-Jun-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
235-380-9
|
12202-17-4
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
235-541-3
|
12267-73-1
|
18-Jun-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
204-650-8
|
123-77-3
|
19-Dez-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | |||
204-661-8
|
123-91-1
|
08-Jul-2021
|
Carcinogenic (Article 57a) Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | |||
235-702-8
|
12578-12-0
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
235-727-4
|
12626-81-2
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
235-759-9
|
12656-85-8
|
13-Jan-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | ||
204-826-4
|
127-19-5
|
19-Dez-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
204-927-3
|
129-00-0
|
15-Jan-2019
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
215-116-9
|
1303-28-2
|
28-Okt-2008
|
Carcinogenic (Article 57a) |
Details | |||
215-125-8
|
1303-86-2
|
18-Jun-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
215-146-2
|
1306-19-0
|
20-Jun-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | ||
215-147-8
|
1306-23-6
|
16-Dez-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
205-017-9
|
131-18-0
|
20-Jun-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
215-235-6
|
1314-41-6
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
215-267-0
|
1317-36-8
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
215-290-6
|
1319-46-6
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
215-481-4
|
1327-53-3
|
28-Okt-2008
|
Carcinogenic (Article 57a) |
Details | |||
215-607-8
|
1333-82-0
|
15-Dez-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
236-542-1
|
13424-46-9
|
19-Dez-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
215-693-7
|
1344-37-2
|
13-Jan-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | ||
237-222-4
|
13701-59-2
|
17-Jan-2023
|
Toxic for reproduction (Article 57c) |
Details | |||
237-486-0
|
13814-96-5
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
205-426-2
|
140-66-9
|
19-Dez-2011
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
205-594-7
|
143-24-8
|
19-Jan-2021
|
Toxic for reproduction (Article 57c) |
Details | |||
ZOLDINE MS-PLUS
|
421-150-7
|
143860-04-2
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
3-benzylidene camphor; 3-BC
|
239-139-9
|
15087-24-8
|
15-Jan-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
239-290-0
|
15245-44-0
|
19-Dez-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
239-622-4
|
15571-58-1
|
17-Dez-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
427-700-2
|
15606-95-8
|
28-Okt-2008
|
Carcinogenic (Article 57a) |
Details | ||
-
|
401-750-5
|
17570-76-2
|
18-Jun-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
205-883-8
|
191-24-2
|
27-Jun-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
217-710-3
|
1937-37-7
|
16-Dez-2013
|
Carcinogenic (Article 57a) |
Details | |||
218-165-4
|
2058-94-8
|
19-Dez-2012
|
vPvB (Article 57e) |
Details | |||
205-912-4
|
206-44-0
|
15-Jan-2019
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
205-916-6
|
207-08-9
|
15-Jan-2019
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
244-073-9
|
20837-86-9
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
244-168-5
|
21041-95-2
|
15-Jan-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
205-923-4
|
218-01-9
|
15-Jan-2018
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
245-152-0
|
22673-19-4
|
25-Jun-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
219-514-3
|
2451-62-9
|
18-Jun-2012
|
Mutagenic (Article 57b) |
Details | |||
246-356-2
|
24613-89-6
|
19-Dez-2011
|
Carcinogenic (Article 57a) |
Details | |||
246-677-8
|
25155-23-1
|
16-Dez-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
500-036-1
|
25214-70-4
|
19-Dez-2011
|
Carcinogenic (Article 57a) |
Details | |||
X4261
|
401-850-9
|
255881-94-8
|
17-Jan-2022
|
PBT (Article 57d) |
Details | ||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
219-943-6
|
2580-56-5
|
18-Jun-2012
|
Carcinogenic (Article 57a) |
Details | ||
247-384-8
|
25973-55-1
|
17-Dez-2014
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
206-104-4
|
301-04-2
|
16-Dez-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
206-114-9
|
302-01-2, 7803-57-8
|
20-Jun-2011
|
Carcinogenic (Article 57a) |
Details | |||
206-203-2
|
307-55-1
|
19-Dez-2012
|
vPvB (Article 57e) |
Details | |||
221-573-5
|
3147-75-9
|
23-Jan-2024
|
vPvB (Article 57e) |
Details | |||
206-397-9
|
335-67-1
|
20-Jun-2013
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
253-037-1
|
36437-37-3
|
17-Dez-2015
|
vPvB (Article 57e) |
Details | |||
222-979-5
|
3687-31-8
|
19-Dez-2011
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
206-803-4
|
376-06-7
|
19-Dez-2012
|
vPvB (Article 57e) |
Details | |||
253-692-3
|
37853-59-1
|
17-Jan-2023
|
vPvB (Article 57e) |
Details | |||
223-320-4
|
3825-26-1
|
20-Jun-2013
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
223-346-6
|
3846-71-7
|
17-Dez-2014
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
223-383-8
|
3864-99-1
|
17-Dez-2015
|
vPvB (Article 57e) |
Details | |||
223-445-4
|
3896-11-5
|
23-Jan-2024
|
vPvB (Article 57e) |
Details | |||
224-208-8
|
4247-02-3
|
17-Jan-2023
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
256-418-0
|
49663-84-5
|
19-Dez-2011
|
Carcinogenic (Article 57a) |
Details | |||
200-028-5
|
50-32-8
|
20-Jun-2016
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
208-168-9
|
513-78-0
|
15-Jan-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
208-169-4
|
513-79-1
|
15-Dez-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
257-175-3
|
51404-69-4
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
D6
|
208-762-8
|
540-97-6
|
27-Jun-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
D5
|
208-764-9
|
541-02-6
|
27-Jun-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
208-953-6
|
548-62-9
|
18-Jun-2012
|
Carcinogenic (Article 57a) |
Details | ||
trimellitic anhydride; TMA
|
209-008-0
|
552-30-7
|
27-Jun-2018
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
D4
|
209-136-7
|
556-67-2
|
27-Jun-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
200-268-0
|
56-35-9
|
28-Okt-2008
|
PBT (Article 57d) |
Details | |||
200-280-6
|
56-55-3
|
15-Jan-2018
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
209-218-2
|
561-41-1
|
18-Jun-2012
|
Carcinogenic (Article 57a) |
Details | ||
209-358-4
|
573-58-0
|
16-Dez-2013
|
Carcinogenic (Article 57a) |
Details | |||
-
|
423-400-0
|
59653-74-6
|
18-Jun-2012
|
Mutagenic (Article 57b) |
Details | ||
200-453-6
|
60-09-3
|
19-Dez-2012
|
Carcinogenic (Article 57a) |
Details | |||
210-088-4
|
605-50-5
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
262-967-7
|
61788-32-7
|
27-Jun-2018
|
vPvB (Article 57e) |
Details | |||
263-467-1
|
62229-08-7
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
210-894-6
|
625-45-6
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
211-076-1
|
629-14-1
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
200-589-6
|
64-67-5
|
19-Dez-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
229-335-2
|
6477-64-1
|
19-Dez-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
266-028-2
|
65996-93-2
|
13-Jan-2010
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
229-851-8
|
6786-83-0
|
18-Jun-2012
|
Carcinogenic (Article 57a) |
Details | ||
200-679-5
|
68-12-2
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
AP-5
|
401-720-1
|
6807-17-6
|
15-Jan-2019
|
Toxic for reproduction (Article 57c) |
Details | ||
211-670-0
|
683-18-1
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
271-084-6
|
68515-42-4
|
20-Jun-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
271-093-5
|
68515-50-4
|
16-Jun-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
with lead (Pb) content above the applicable generic concentration limit for ’toxicity for reproduction’ Repr. 1A (CLP) or category 1 (DSD),the substance is a member of the group entry of lead compounds, with index number 082-001-00-6 in Regulation (EC) No 1272/2008
|
272-271-5
|
68784-75-8
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
273-688-5
|
69011-06-9
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
211-765-7
|
693-98-1
|
25-Jun-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
200-755-8
|
71-48-7
|
15-Dez-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
276-090-2
|
71850-09-4
|
16-Jan-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
|
400-600-6
|
71868-10-5
|
16-Jan-2020
|
Toxic for reproduction (Article 57c) |
Details | ||
276-158-1
|
71888-89-6
|
20-Jun-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
276-745-2
|
72629-94-8
|
19-Dez-2012
|
vPvB (Article 57e) |
Details | |||
211-989-5
|
732-26-3
|
23-Jan-2024
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
231-100-4
|
7439-92-1
|
27-Jun-2018
|
Toxic for reproduction (Article 57c) |
Details | |||
231-152-8
|
7440-43-9
|
20-Jun-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
200-842-0
|
75-12-7
|
18-Jun-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
200-879-2
|
75-56-9
|
19-Dez-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
278-355-8
|
75980-60-8
|
14-Jun-2023
|
Toxic for reproduction (Article 57c) |
Details | |||
231-556-4
|
7632-04-4
|
16-Jun-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
231-589-4
|
7646-79-9
|
28-Okt-2008
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
201-004-7
|
77-09-8
|
19-Dez-2011
|
Carcinogenic (Article 57a) |
Details | |||
201-025-1
|
77-40-7
|
08-Jul-2021
|
Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
201-058-1
|
77-78-1
|
19-Dez-2012
|
Carcinogenic (Article 57a) |
Details | |||
231-846-0
|
7758-97-6
|
13-Jan-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
-
|
776297-69-9
|
19-Dez-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
231-889-5
|
7775-11-3
|
18-Jun-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
231-901-9
|
7778-39-4
|
19-Dez-2011
|
Carcinogenic (Article 57a) |
Details | |||
231-904-5
|
7778-44-1
|
19-Dez-2011
|
Carcinogenic (Article 57a) |
Details | |||
231-906-6
|
7778-50-9
|
18-Jun-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
232-064-2
|
7784-40-9
|
28-Okt-2008
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
232-140-5
|
7789-00-6
|
18-Jun-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
232-142-6
|
7789-06-2
|
20-Jun-2011
|
Carcinogenic (Article 57a) |
Details | |||
232-143-1
|
7789-09-5
|
18-Jun-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
232-222-0
|
7790-79-6
|
17-Dez-2014
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||